| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
| 03/04/2004 | WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 03/04/2004 | WO2003053463A3 Poxvirus-containing compositions and process for their preparation |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003051365A3 Use of compounds of the benzamide family as immunosuppressant |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003043574A3 Pharmaceutical compositions in particulate form |
| 03/04/2004 | WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 03/04/2004 | WO2003025176A8 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 03/04/2004 | WO2003017924A3 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 03/04/2004 | WO2003011114A3 Methods for treating prostatitis |
| 03/04/2004 | WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses |
| 03/04/2004 | WO2003007986A3 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 03/04/2004 | WO2002100900A3 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002092818A8 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044207 Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 03/04/2004 | US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044052 N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043980 Bactericides; storage stability |
| 03/04/2004 | US20040043978 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/04/2004 | US20040043945 Crystal forms of azithromycin |
| 03/04/2004 | US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance |
| 03/04/2004 | US20040043939 Peptide-based gemini compounds |
| 03/04/2004 | US20040043936 Antiproliferative and antiviral proteins and peptides |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043380 A T cell line carrying a reporter gene that contains an long terminal repeat (LTR) sequence of Human Immunodeficiency Virus (HIV); for use in an efficient screening method for efficiently finding out a medicine such as an anti-HIV agents |
| 03/04/2004 | US20040043039 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsides |
| 03/04/2004 | US20040043035 Recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 03/04/2004 | US20040043002 Polyol-IFN-beta conjugate and composition containing same |
| 03/04/2004 | US20040042978 Mixture of stannous fluoride and zinc compound |
| 03/04/2004 | US20040042960 Use of moulding compounds for producing treatment devices |
| 03/04/2004 | US20040040554 Binding of end groups to virus |
| 03/04/2004 | DE10239531A1 Prophylaxe und Therapie von Infektionserkrankungen Prophylaxis and therapy of infectious diseases |
| 03/04/2004 | DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2513416A1 Novel antibacterial agents |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2497582A1 Prophylaxis and treatment of infectious diseases |
| 03/04/2004 | CA2496215A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/04/2004 | CA2494953A1 Beta-lactamase inhibitor prodrug |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | CA2494164A1 Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| 03/03/2004 | EP1394259A2 Recombinant infectious non-segmented negative strand RNA virus |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394184A1 Apoptose inhibitor |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1393746A1 Human polyclonal antibody compositions |
| 03/03/2004 | EP1393744A1 Acellular pertussis vaccines and methods of preparation thereof |
| 03/03/2004 | EP1393743A1 Agents modulating UPA/UPAR activity for the treatment of AIDS |
| 03/03/2004 | EP1393728A1 Inverse agonists acting at virus-encoded G protein-coupled receptors |
| 03/03/2004 | EP1392855A2 Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392830A2 Interleukin-18 mutants, their production and use |
| 03/03/2004 | EP1392704A1 Cephem compounds |
| 03/03/2004 | EP1392695A2 Triazolopyrimidines |
| 03/03/2004 | EP1392691A1 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4 u H /u -PYRROLO 1,2-A] 1,4]BENZODIAZEPINES |
| 03/03/2004 | EP1392686A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 03/03/2004 | EP1392685A1 Tropane alkaloid multidrug resistance inhibitors from erythroxylum pervillei and use of the same |
| 03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392666A1 Biologically active methylene blue derivatives |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
| 03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 03/03/2004 | EP1392389A2 Microprojection array having a beneficial agent containing coating |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392344A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor |
| 03/03/2004 | EP1392341A2 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof |
| 03/03/2004 | EP1392334A2 Therapeutic methods using herbal compositions |